Related Experiment Video
Updated: Aug 6, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
Published on: May 1, 2015
Tachykinins and their receptors in human malignancies
1Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy. c.palma@iss.it
Abstract:
The possibility of links between psychosocial factors and cancer incidence and progression has generated considerable scientific and public interest. Tachykinins, including substance P, neurokinin A and B, hemokinin-1 and endokinins, are a family of neuropeptides, acting through three types of transmembrane G-protein coupled receptors denoted NK1, NK2 and NK3. Besides their role as neurotransmitters in peripheral and central nervous system, tachykinins and their receptors are also expressed in several non neuronal cells contributing to the fine connections between nervous systems and peripheral organ system such as respiratory, cardiovascular, immune, endocrine, gastrointestinal and genitourinary. Being so much involved in regulating physiological functions, they, of course, can concur to pathological conditions including cancer. Tachykinins can act on different steps of carcinogenesis. Tumors expressing NK receptors, such as astrocytoma, glioma, neuroblastoma, pancreatic cancer and melanoma, can misuse tachykinin-induced signaling, operating in normal cells, to promote proliferation and survival of cancer cells and to release cytokines and soluble mediators favoring tumor growth. In neuroblastoma, breast and prostate carcinomas tachykinins facilitate tumor metastatic infiltration in the bone marrow. In neuroendocrine carcinoma, tachykinins are responsible of symptoms associated with these pathologies including flushing, diarrhea, wheezing and right heart disease. In addition, regardless tumor histology, tachykinins may favor cancer incidence and metastatic progression by influencing blood flux and neovascularization in tumor formation as well as inducing immunosuppression mediated by neurogenic inflammation due to stress or surgery. However, the precise involvement of tachykinins in cancer pathologies and the potentiality to become effective pharmacological drug targets remain to be fully defined.
Insights
Neuropeptides called tachykinins and their receptors are implicated in cancer development and spread. Further research is needed to fully define their role and potential as cancer drug targets.
Area of Science:
- Neuroscience
- Oncology
- Molecular Biology
Background:
- Tachykinins are neuropeptides that regulate physiological functions and are involved in pathological conditions, including cancer.
- Tachykinins and their receptors (NK1, NK2, NK3) are expressed in both neuronal and non-neuronal cells, highlighting their systemic influence.
- Their involvement in processes like cell proliferation, survival, and immune response suggests a role in carcinogenesis.
Purpose of the Study:
- To explore the multifaceted roles of tachykinins in various stages of cancer development and progression.
- To investigate how tachykinins and their receptors contribute to tumor growth, metastasis, and associated symptoms.
- To assess the potential of targeting tachykinin signaling pathways for cancer therapy.
Main Methods:
- Review and synthesis of existing scientific literature on tachykinins, their receptors, and their involvement in cancer.
- Analysis of studies examining tachykinin expression in different cancer types (e.g., astrocytoma, neuroblastoma, breast cancer).
- Examination of evidence linking tachykinin signaling to cancer cell proliferation, survival, metastasis, and tumor microenvironment modulation.
Main Results:
- Tachykinins can promote cancer cell proliferation and survival by hijacking normal signaling pathways in tumors expressing NK receptors.
- They facilitate tumor metastasis, particularly in bone marrow, and contribute to symptoms in neuroendocrine carcinomas.
- Tachykinins influence angiogenesis and immunosuppression, potentially increasing cancer incidence and progression.
Conclusions:
- Tachykinins play a significant role in multiple aspects of cancer, from initiation to metastatic spread.
- Their involvement in tumor growth, symptom manifestation, and immune modulation underscores their complex contribution to cancer pathology.
- While promising as therapeutic targets, the precise mechanisms and clinical efficacy require further comprehensive investigation.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Mitogens and the Cell Cycle
The Tumor Microenvironment
Abnormal Proliferation

